Category: St. Jude Medical
St. Jude Medical says that its Quartet quadripolar leads "performed better than bipolar leads of any kind" in a recent mega-study.
Medical device giant St. Jude Medical (NYSE:STJ) had high praise for its own quadripolar leads, saying that blow away any competition from older bipolar leads.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Researchers report that St. Jude Medical's fractional flow reserve technology helps slash adverse events, especially urgent revascularizations, compared with medical therapy alone.
The failure of Medtronic's Symplicity 3 trial doesn't mean the end of renal denervation in treated resistant hypertension, especially in Europe, but future studies face a high bar set by the Medtronic trial's sham control arm.
A federal judge agrees to toss a lawsuit filed against Johnson & Johnson's Biosense Webster by a former sales rep and her new employer, St. Jude Medical.
St. Jude Medical says the FDA cleared a 2009 warning letter issued over a plant in Plano, Texas, that makes neuromodulation devices.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Valeant's hostile takeover hopes fade as Allergan war continues; Medtronic hires ex-Senators to lobby for Covidien deal; FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; St. Jude closes $200M NeuroTherm buy; Medtronic-Covidien merger means tax hit for all stockholders, including execs